Cargando…
Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies
BACKGROUND: The WHO considers leishmaniasis as one of the six most important tropical diseases worldwide. It is caused by parasites of the genus Leishmania that are passed on to humans and animals by the phlebotomine sandfly. Despite all of the research, there is still a lack of understanding on the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293051/ https://www.ncbi.nlm.nih.gov/pubmed/22222070 http://dx.doi.org/10.1186/1752-0509-6-1 |
_version_ | 1782225360959569920 |
---|---|
author | Länger, Bettina M Pou-Barreto, Cristina González-Alcón, Carlos Valladares, Basilio Wimmer, Bettina Torres, Néstor V |
author_facet | Länger, Bettina M Pou-Barreto, Cristina González-Alcón, Carlos Valladares, Basilio Wimmer, Bettina Torres, Néstor V |
author_sort | Länger, Bettina M |
collection | PubMed |
description | BACKGROUND: The WHO considers leishmaniasis as one of the six most important tropical diseases worldwide. It is caused by parasites of the genus Leishmania that are passed on to humans and animals by the phlebotomine sandfly. Despite all of the research, there is still a lack of understanding on the metabolism of the parasite and the progression of the disease. In this study, a mathematical model of disease progression was developed based on experimental data of clinical symptoms, immunological responses, and parasite load for Leishmania amazonensis in BALB/c mice. RESULTS: Four biologically significant variables were chosen to develop a differential equation model based on the GMA power-law formalism. Parameters were determined to minimize error in the model dynamics and time series experimental data. Subsequently, the model robustness was tested and the model predictions were verified by comparing them with experimental observations made in different experimental conditions. The model obtained helps to quantify relationships between the selected variables, leads to a better understanding of disease progression, and aids in the identification of crucial points for introducing therapeutic methods. CONCLUSIONS: Our model can be used to identify the biological factors that must be changed to minimize parasite load in the host body, and contributes to the design of effective therapies. |
format | Online Article Text |
id | pubmed-3293051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32930512012-03-05 Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies Länger, Bettina M Pou-Barreto, Cristina González-Alcón, Carlos Valladares, Basilio Wimmer, Bettina Torres, Néstor V BMC Syst Biol Research Article BACKGROUND: The WHO considers leishmaniasis as one of the six most important tropical diseases worldwide. It is caused by parasites of the genus Leishmania that are passed on to humans and animals by the phlebotomine sandfly. Despite all of the research, there is still a lack of understanding on the metabolism of the parasite and the progression of the disease. In this study, a mathematical model of disease progression was developed based on experimental data of clinical symptoms, immunological responses, and parasite load for Leishmania amazonensis in BALB/c mice. RESULTS: Four biologically significant variables were chosen to develop a differential equation model based on the GMA power-law formalism. Parameters were determined to minimize error in the model dynamics and time series experimental data. Subsequently, the model robustness was tested and the model predictions were verified by comparing them with experimental observations made in different experimental conditions. The model obtained helps to quantify relationships between the selected variables, leads to a better understanding of disease progression, and aids in the identification of crucial points for introducing therapeutic methods. CONCLUSIONS: Our model can be used to identify the biological factors that must be changed to minimize parasite load in the host body, and contributes to the design of effective therapies. BioMed Central 2012-01-05 /pmc/articles/PMC3293051/ /pubmed/22222070 http://dx.doi.org/10.1186/1752-0509-6-1 Text en Copyright ©2012 Länger et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Länger, Bettina M Pou-Barreto, Cristina González-Alcón, Carlos Valladares, Basilio Wimmer, Bettina Torres, Néstor V Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies |
title | Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies |
title_full | Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies |
title_fullStr | Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies |
title_full_unstemmed | Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies |
title_short | Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies |
title_sort | modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293051/ https://www.ncbi.nlm.nih.gov/pubmed/22222070 http://dx.doi.org/10.1186/1752-0509-6-1 |
work_keys_str_mv | AT langerbettinam modelingofleishmaniasisinfectiondynamicsnovelapplicationtothedesignofeffectivetherapies AT poubarretocristina modelingofleishmaniasisinfectiondynamicsnovelapplicationtothedesignofeffectivetherapies AT gonzalezalconcarlos modelingofleishmaniasisinfectiondynamicsnovelapplicationtothedesignofeffectivetherapies AT valladaresbasilio modelingofleishmaniasisinfectiondynamicsnovelapplicationtothedesignofeffectivetherapies AT wimmerbettina modelingofleishmaniasisinfectiondynamicsnovelapplicationtothedesignofeffectivetherapies AT torresnestorv modelingofleishmaniasisinfectiondynamicsnovelapplicationtothedesignofeffectivetherapies |